EPS Estimate Of Hologic, Inc. (NASDAQ:HOLX) At $0.55
- Investor Newswire
Earnings estimations are figured by equity analysts for valuing the productivity and movement of a firm in different periods. Hologic
, Inc. (NASDAQ:HOLX) announced earnings surprise of 8.51% for the period ending on 2016-06-30. The EPS of $0.51 was ...
Is Hologic Inc.(NASDAQ: HOLX), a large market cap stock a smart buy?
- The Daily Leicester
With a market cap of has a large market cap size. Hologic
Inc. (NASDAQ: HOLX) has been on the stock market since its IPO date on the 3/26/1990. Hologic
Inc. is in the Medical Appliances & Equipment industry and Healthcare sector. Average volume for ...
Hologic Inc. (NASDAQ:HOLX) Assigned A Consensus Outperform Rating
- The Independent RepublicHologic
Inc. (NASDAQ:HOLX) stock is currently trading at about $38.47 and lots of rating firms seem to have a target price set on the stock. The median 12-month price target of 15 analysts covering the company is $44.00, which suggests the stock could ...
Zacks Assigns Rating Of 1.88 To Hologic, Inc. (NASDAQ:HOLX)
- Enterprise Leader
Zacks has positive score on Hologic
, Inc. (NASDAQ:HOLX) on basis of reported strong financial numbers. The comprehensive analysis process considers the diverse financial numbers and sets the growth figures. While completing this study, professionals ...
New High Updates for Hologic Inc. (NASDAQ:HOLX)
- The News Journal
Amid the all-time high stocks in today's market is Hologic
Inc. (NASDAQ:HOLX) that had a market cap of 10636.19. The company's P/E was valued at 42 as it measures its current share price to its per-share earnings. At present, (NASDAQ:HOLX)'s price is ...
Hologic CEO, Steve MacMillan, on Fox Business Mornings with Maria
Hologic’s Proprietary Real-Time TMA
Hologic CEO on Fox Opening Bell – May 1 Hologic
Hologic 3D MAMMOGRAPHY™ Exam Patient Video
Hologic's 3D mammography system becomes first to get FDA approval
Hologic Affirm Prone Breast Biopsy System
Hologic, Inc. The Women's Health Company
Developer, manufacturer and supplier of diagnostic and surgical products, and medical imaging systems involved in women's health. Features product inventory and ...
Hologic corporation is a developer, manufacturer and supplier of diagnostic and medical imaging systems related to women's health. It develops digital imaging ...
Hologic Inc. Stock - HOLX news, historical stock charts, analyst ratings, financials, and today’s Hologic Inc. stock price.
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health.
At Hologic, we are dedicated to transforming breast cancer screening and diagnosis to ensure radiologists can find even the most invasive cancers at the earliest ...
Stock quote for Hologic, Inc. Common Stock (HOLX) - Get real-time last sale and extended hours stock prices, company news, charts, and company-specific research tools ...
Updated stock quote for HOLX - including HOLX stock price today, earnings and estimates, stock charts, news, futures and other investing data.
More consistency, clarity and cellularity from every block. The Cellient™ Automated Cell Block System is the first fully automated cell block system.
Hologic, Inc. ThinPrep® 2000 System Instructions for Use INTENDED USE The ThinPrep ® 2000 System is intended as a replacement for the conventional method of Pap smear
NovaSure endometiral ablations is an FDA-approved procedure that may lighten or end your patients' heavy menstrual bleeding with no hormonal side effects.
Hologic corporation is a developer, manufacturer and supplier of diagnostic and medical imaging systems related to women's health. It develops digital imaging technology for general radiography and mammography applications. Its core business divisions are focused on three areas: Breast and Skeletal Health, Surgical GYN and Cervical & Molecular Diagnostics. It's major brands include Lorad, Fluoroscan, Thinprep, Aptima, NovaSure, MyoSure, Selenia, Securview, Discovery, Multicare and Directray.Hologic is a leader in women's healthcare, particularly breast cancer diagnosis.Hologic is currently developing tomosynthesis technology for breast cancer diagnosis. Hologic first demonstrated the technology at the Radiological Society of North America in November 2003. It provided patient images and a prototype add-on to its Selenia digital mammography system. Clinical trials for Hologic's tomosynthesis technology began in the summer of 2004.Hologic was the recipient of Frost and Sullivan's 2004 Technology Leadership of the Year Award in women's healthcare.